Results 211 to 220 of about 156,654 (268)

Immunogenic Cell Death: Unlocking New Frontiers in Cancer Immunotherapy. [PDF]

Cancer Innov
Yaacoub K.
europepmc   +1 more source

Plant-Derived Compounds as Potential Sensitizers to Immunotherapy in Melanoma. [PDF]

Int J Mol Sci
Bătrîna O, Negrea-Ghiulai R, Suciu L, Racoviceanu R, Atyim E, Jorgovan M, Maksimovic T, Mioc A, Trandafirescu C, Șoica C, Mioc M.   +10 more
europepmc   +1 more source

Evaluating the Therapeutic Impact of Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer. [PDF]

Biomedicines
Rouvinov K, Naamneh R, Yakobson A, Soklakova A, Najjar W, Abu Amna M, Asla M, Abu Jama A, Abu Yasin N, Abu Juda M, Abu Freih S, Malek Y, Shalata W.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Active Immunotherapy of Cancer

Immunological Investigations, 2015
Clinical progress in the field of cancer immunotherapy has been slow for many years but within the last 5 years, breakthrough successes have brought immunotherapy to the forefront in cancer therapy. Promising results have been observed in a variety of cancers including solid tumors and hematological malignancies with adoptive cell therapy using natural
Thinle, Chodon, Richard C, Koya, Kunle, Odunsi   +2 more
openaire   +2 more sources

Active immunotherapy in colorectal cancer

Seminars in Surgical Oncology, 1989
AbstractSeventy‐four patients with Dukes' B2 through C3 colon or rectal cancer were entered into a prospectively randomized, controlled trial of active specific immunotherapy (ASI) with an autologous tumor cell‐BCG vaccine. Primary tumors were dissociated enzymatically and cryopreserved by techniques that maintain cell viability.
H C, Hoover, M G, Hanna
openaire   +2 more sources

Active immunotherapy of multiple myeloma

European Journal of Cancer, 2006
Since myeloma cells express various potential target antigens, active immunotherapy is being investigated as a novel treatment modality for myeloma. Immunization against the clonal myeloma immunoglobulin (idiotype) elicits protective immunity in mouse models.
Houet, Leonora, Veelken, Hendrik
openaire   +3 more sources

Active specific immunotherapy of melanoma

British Medical Bulletin, 1995
Active specific immunotherapy, or the use of tumor 'vaccines', attempts to stimulate the patient to reject his or her tumor. Nowhere has this approach been utilized more than in melanoma, often with encouraging results. The best results have occurred in the setting of minimal residual disease after resection of the primary tumor and involved lymph ...
openaire   +2 more sources